Reviews
Summary
Positives
- In the DELong#3 placebo-controlled pilot, long-haulers taking VSL#3 sachets twice a day for four weeks had significantly lower Chalder Fatigue Scale scores that persisted four weeks after stopping medRxiv DELong#3.
- An IBS trial found VSL#3 reduced colonic permeability and abdominal pain, mechanisms relevant to leaky-gut symptoms in Long COVID Frontiers in Pain Research.
Negatives
- A review of post-COVID probiotic data flagged that the VSL#3 fatigue pilot was small (n=38) and not powered to detect harms or non-fatigue outcomes MDPI Molecules review.
Hurdles & Side Effects
- The protocol requires two cold-chain sachets daily, which is expensive and logistically taxing for housebound patients medRxiv DELong#3.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care